4:30 pm dinner and presentation (4 pm registration)
Nurses Taking Action: The Proactive Approach
Oncology nurses have an important role in the management of patients with cancer. This interactive program will provide you with clinical information and resources about anemia, neutropenia, and bone health. Learn more and register.
4:30-5:30 pm (4 pm Registration)
Optimizing VELCADE® (bortezomib) Therapy for Advanced Practitioners
Join us for dinner! Learn more about this ancillary event opportunity.
1.75 contact hours
Susan Leigh, RN, BSN, Survivorship Navigator
In From Idealism to Realism: Current Perspectives on Cancer Survivorship, Susan Leigh, RN, BSN, will discuss the background of the cancer survivorship movement, provide examples of the physical and psychosocial impacts of surviving cancer care, and highlight the challenges of implementing survivorship care planning in the busy day-to-day nursing world, where the ideal does not always translate to reality.
Leigh is an oncology nurse and cancer survivorship consultant who is also a long-term survivor of Hodgkin's disease, breast cancer, and carcinoma in situ of the bladder. She is a founding member and past president of the National Coalition for Cancer Survivorship.
- Understand the history and relevance of the consumer-driven survivorship movement.
- Describe the elements, mandates and challenges of survivorship care planning.
- Recognize the dimensions of advocacy and how they relate to both survivors and healthcare providers.
The Role of Cytogenetics in Hematologic Malignancies
1.5 contact hours
Sid Ganguly, MD
In this session, you'll learn to recognize and interpret different cytogenetic abnormalities in hematologic malignancies and gain a better understanding of risk prognostication based on cytogenetic analysis.
- Recognize and interpret different cytogenetic abnormalities in hematological malignancies.
- Understand risk prognostication of hematological malignancies based on cytogenetic analysis.
1.5 contact hours
Sid Ganguly, MD
Using CML as a model, you'll learn to monitor disease response based on serial cytogenetics, FISH, and PCR-based analysis. Then, discover how cytogenetic reports help to determine treatment regimens.
- Monitoring of disease response based on serial cytogenetics, FISH, and PCR-based analysis using CML as a model.
- Understand how the cytogenetic report assists in determining treatment regimens.
Box Lunch in Exhibit Hall
1.0 contact hours
Laura Zitella MS, ACNP-BC, AOCN
Find out how inflammation affects iron-deficiency anemia, including its effect on the interpretation of relevant lab test results and on targeting iron-replacement appropriately. You'll also learn more about the pathophysiologic process of hemolysis and delineate relevant interventions for its management.
- Discuss the impact of inflammation in the setting of iron-deficiency anemia, including interpreting relevant lab test results and targeting iron-replacement appropriately.
- Discuss the pathophysiologic process of hemolysis and delineate relevant interventions for its management.
1.0 contact hour
Suni Elgar, RN, BSN, OCN
Learn more about what patients can expect when they return home after transplant, including common post-transplant problems and conditions that need to be monitored. Speakers will also discuss the communication process between the transplant center and referring provider.
- Describe what to expect when the patient returns home after transplant.
- Discuss conditions to monitor and the most common problems after transplant.
- Describe the communication process between the transplant center and referring provider.
1.25 contact hours
Mikela Lidtke, M.D. (Anaheim)
Morie A. Gertz, MD, MACP (Indianapolis)
Francis Buadi, MD, ChB (Dallas)
Can you describe the pathophysiologic mechanisms involved in amyloidosis? You'll be able to after this session, where you'll discuss the specific organ dysfunction seen in this disorder (cardiac, renal, neurologic). Speakers will place a particular emphasis on relevant assessment methods and strategies to minimize associated symptoms. They'll also discuss treatment options and their efficacy.
- Describe the pathophysiologic mechanisms involved in amyloidosis.
- Discuss the specific organ dysfunction seen in this disorder (cardiac, renal, neurologic), emphasizing relevant assessment methods and strategies to minimize associated symptoms.
- Delineate treatment options for amyloidosis and the efficacy of each.
Assessment and Treatment of CIPN
1.00 contact hours
Cindy S. Tofthagen, PhD, ARNP, AOCNP® (Anaheim & Dallas)
Ellen M. Lavoie Smith, PhD, APRN, AOCN (Indianapolis)
Cindy Tofthagen, PhD, ARNP, AOCNP, assistant professor at the University of South Florida in Tampa and nurse practitioner in medical oncology will present "Prevention and Management of Neuropathies". She will discuss genetic and pre-existing risk factors for developing neuropathies and prevention and treatment modalities for neuropathies in the hematology/oncology population.
- Identify genetic and pre-existing risk factors for developing neuropathies.
- Describe prevention and treatment modalities for neuropathies.